Equities

Emergent BioSolutions Inc

Emergent BioSolutions Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)6.22
  • Today's Change0.042 / 0.68%
  • Shares traded350.00
  • 1 Year change+77.30%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments112643576
Total Receivables, Net191159275
Total Inventory329351351
Prepaid expenses485870
Other current assets, total--00.20
Total current assets6801,2101,272
Property, plant & equipment, net399837828
Goodwill, net0218225
Intangibles, net567729605
Long term investments------
Note receivable - long term------
Other long term assets17817229
Total assets1,8233,1662,959
LIABILITIES
Accounts payable112104129
Accrued expenses96128146
Notes payable/short-term debt000
Current portion long-term debt/capital leases41495732
Other current liabilities, total294067
Total current liabilities6511,229374
Total long term debt447449809
Total debt8601,406841
Deferred income tax476095
Minority interest------
Other liabilities, total294262
Total liabilities1,1741,7791,340
SHAREHOLDERS EQUITY
Common stock0.100.100.10
Additional paid-in capital904874829
Retained earnings (accumulated deficit)(22)739958
Treasury stock - common(228)(228)(152)
Unrealized gain (loss)------
Other equity, total(5.7)3.10(16)
Total equity6491,3881,619
Total liabilities & shareholders' equity1,8233,1662,959
Total common shares outstanding525051
Treasury shares - common primary issue5.605.603.80
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.